Rutgers researchers have developed a point-of-care tool that can rapidly assess the sensitivity of tumor cells to cancer drugs without staining or labeling.
A diverse group of researchers and diagnostic industry participants has collaborated to produce two papers that describe and critique Lyme disease testing technologies.
The researchers described the development of a venipuncture robot that addresses safety challenges associated with routine vein punctures for drawing blood.
A new laboratory being created as part of the collaboration will further study the correlation between changes in biomarkers and changes in athletic performance.
The researchers said that their nanoparticle technology, which detects infrared light, could eventually guide more precise breast cancer surgeries.
The university is leveraging CDC funding to validate PCR and real-time PCR assays for detecting Candida auris in hospitals.